ADH1B Knockout HAP1 Polyclonal Cells consist of a heterogeneous population of near-haploid HAP1 cells engineered via CRISPR/Cas9-mediated gene disruption to ablate expression of the ADH1B locus. Unlike clonal isolates, this polyclonal format avoids selection biases and provides a robust model for studying ethanol metabolism and its toxicological consequences at the population level. The ADH1B gene targeting introduces loss-of-function mutations, leading to the absence of functional alcohol dehydrogenase 1B protein, enabling direct investigation of pathway perturbations without genetic compensation artifacts often observed in clonal lines.
The HAP1 parental cell line is derived from a chronic myelogenous leukemia patient and features a near-haploid karyotype, a property that greatly facilitates genetic knockout studies by eliminating allelic redundancy. This hematopoietic cell line exhibits stable growth and is permissive to efficient CRISPR/Cas9 editing, making it an ideal platform for creating polyclonal knockout pools. Its near-haploid genome simplifies genotype-phenotype correlations, allowing researchers to attribute observed phenotypic changes directly to the engineered disruption. Moreover, HAP1 cells retain relevant metabolic and signaling pathways, rendering them suitable for physiologically meaningful biochemical analyses.
ADH1B encodes the alcohol dehydrogenase 1B subunit, a key enzyme in ethanol oxidation that converts ethanol to acetaldehyde while reducing NAD+ to NADH. The active enzyme functions as a homodimer and is classified within the ADH isozyme family. Its transcription is governed by upstream regulators including HNF4A, retinoids, and glucocorticoids. Catalytic activity leads to the production of acetaldehyde??a reactive and potentially mutagenic metabolite??and NADH, which influences the cellular redox state. Downstream, acetaldehyde is further metabolized by ALDH2, and imbalances in NADH/NAD+ ratio can affect fatty acid oxidation and lipid homeostasis. Additionally, ADH1B-mediated reactions generate reactive oxygen species, contributing to oxidative stress and DNA damage.
In the HAP1 context, ADH1B knockout holds significant relevance for cancer biology and toxicology, given acetaldehyde??s classification as a Group 1 carcinogen by IARC. This model enables the dissection of acetaldehyde-induced genotoxicity mechanisms, which are implicated in esophageal and head and neck squamous cell carcinomas. The genetic simplicity of HAP1 cells reduces confounding factors, allowing clear examination of DNA adduct formation, repair responses, and cell cycle checkpoint activation in the absence of ADH1B activity. Furthermore, this knockout can be employed to study alcohol dependence-related pathways and the alcohol flush reaction, as ADH1B polymorphisms are strongly associated with these phenotypes in human populations.
Typical research applications include metabolic flux analysis of ethanol clearance, quantification of acetaldehyde accumulation, and assessment of NADH/NAD+ ratios using enzymatic or fluorescent assays. Genotoxicity can be evaluated through Comet assays and DNA adduct detection, while molecular validation is performed via Western blotting and RT-qPCR. These polyclonal knockout cells are also suitable for investigating the interplay between ethanol metabolism, oxidative stress, and cellular transformation, as well as for screening compounds that modulate aldehyde toxicity. For more information regarding this knockout model, please reach out to Ascent Research.
